guaifenesin and pseudoephedrine hcl
Generic: guaifenesin and pseudoephedrine hcl
Labeler: rite aid corporationDrug Facts
Product Profile
Brand Name
guaifenesin and pseudoephedrine hcl
Generic Name
guaifenesin and pseudoephedrine hcl
Labeler
rite aid corporation
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
guaifenesin 600 mg/1, pseudoephedrine hydrochloride 60 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
11822-0046
Product ID
11822-0046_a03e6b5b-fed4-dd64-160d-be1315e7cece
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA208369
Listing Expiration
2026-12-31
Marketing Start
2022-02-01
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
118220046
Hyphenated Format
11822-0046
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
guaifenesin and pseudoephedrine hcl (source: ndc)
Generic Name
guaifenesin and pseudoephedrine hcl (source: ndc)
Application Number
ANDA208369 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 600 mg/1
- 60 mg/1
Packaging
- 1 BLISTER PACK in 1 CARTON (11822-0046-1) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
- 2 BLISTER PACK in 1 CARTON (11822-0046-2) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a03e6b5b-fed4-dd64-160d-be1315e7cece", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["1305603"], "spl_set_id": ["9fb0c938-d24b-2371-95db-6c82d9511d72"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Rite Aid Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (11822-0046-1) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "11822-0046-1", "marketing_start_date": "20220201"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (11822-0046-2) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "11822-0046-2", "marketing_start_date": "20220201"}], "brand_name": "Guaifenesin and Pseudoephedrine HCl", "product_id": "11822-0046_a03e6b5b-fed4-dd64-160d-be1315e7cece", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "11822-0046", "generic_name": "Guaifenesin and Pseudoephedrine HCL", "labeler_name": "Rite Aid Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin and Pseudoephedrine HCl", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "ANDA208369", "marketing_category": "ANDA", "marketing_start_date": "20220201", "listing_expiration_date": "20261231"}